Structural basis for the interaction of human β-defensin 6 and its putative chemokine receptor CCR2 and breast cancer microvesicles

Journal of Molecular Biology

Volumn 425, Issue 22, 2013, Pages 4479-4495

  De Paula, V S ^a   Gomes, N S F ^a   Lima, L G ^a   Miyamoto, C A ^b   Monteiro, R Q ^a   Almeida, F C L ^a   Valente, A P ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Faculdades Integradas de Três Lagoas AEMS   (Brazil)

Author keywords

backbone dynamics; CCR2; innate immune system; NMR; defensin

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 1; BETA DEFENSIN 6; CHEMOKINE RECEPTOR CCR2; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BREAST CANCER; CANCER CELL; CARBOXY TERMINAL SEQUENCE; CELL VACUOLE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; HUMAN; HUMAN CELL; LIPID VESICLE; MOLECULAR DOCKING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

EID: 84886727035     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2013.08.001     Document Type: Article

References (60)

1. D. Yang, A. Biragyn, L.W. Kwak, and J.J. Oppenheim Mammalian defensins in immunity: more than just microbicidal Trends Immunol 23 2002 291 296
2. R.I. Lehrer, and T. Ganz Defensins of vertebrate animals Curr Opin Immunol 14 2002 96 102
3. D. Yang, O. Chertov, S.N. Bykovskaia, Q. Chen, M.J. Buffo, and J. Shogan β-Defensins: linking innate and adaptive immunity through dendritic and T cell CCR6 Science 286 1999 525 528
4. J. Röhrl, D. Yang, J.J. Oppenheim, and T. Hehlgans Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2 J Immunol 184 2010 6688 6694
5. K.L. Lin, Y. Suzuki, H. Nakano, E. Ramsburg, and M.D. Gunn CCR2 + monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality J Immunol 180 2008 2562 2572
6. T. Jia, N.V. Serbina, K. Brandl, M.X. Zhong, I.M. Leiner, and I.F. Charo Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection J Immunol 180 2008 6846 6853
7. W.B. Fang, I. Jokar, A. Zou, D. Lambert, P. Dendukuri, and N. Cheng CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 and p42/44MAPK dependent mechanisms J Biol Chem 287 2012 36593 36608
8. L. Hazlett, and M. Wu Defensins in innate immunity Cell Tissue Res 343 2011 175 188
9. D.O. Croci, M.F. Zacarías Fluck, M.J. Rico, P. Matar, G.A. Rabinovich, and O.G. Scharovsky Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment Cancer Immunol Immunother 56 2007 1687 1700
10. C.Q. Sun, R. Arnold, C. Fernandez-Golarz, A.B. Parrish, T. Almekinder, and J. He Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma Cancer Res 66 2006 8542 8549
11. G. Jin, H.I. Kawsar, S.A. Hirsch, C. Zeng, X. Jia, and Z. Feng An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis PLoS One 5 2010 1 14
12. S. Coffelt, and A. Scandurro Tumors sound the alarmin(s) Cancer Res 68 2008 6482 6485
13. Y. Liu, and G. Zeng Cancer and innate immune system interactions: translational potentials for cancer immunotherapy J Immunother 35 2012 299 308
14. E.M. Bevers, P. Comfurius, and R.F. Zwaal Regulatory mechanisms in maintenance and modulation of transmembrane lipid asymmetry: pathophysiological implications Lupus 5 1996 480 487
15. S. Riedl, D. Zweytick, and K. Lohner Membrane-active host defense peptides - challenges and perspectives for the development of novel anticancer drugs Chem Phys Lipids 164 2011 766 781
16. M.T. Santini, R. Romano, G. Rainaldi, P. Filippini, E. Bravo, and L. Porcu The relationship between 1H-NMR mobile lipid intensity and cholesterol in two human tumor multidrug resistant cell lines (MCF-7 and LoVo) Biochim Biophys Acta 1531 2001 111 131
17. C. Peetla, R. Bhave, S. Vijayaraghavalu, A. Stine, E. Kooijman, and V. Labhasetwar Drug resistance in breast cancer cells: biophysical characterization of and doxorubicin interactions with membrane lipids Mol Pharm 7 2010 2334 2348
18. T.H. Lee, E. D'Asti, N. Magnus, K. Al-Nedawi, B. Meehan, and J. Rak Microvesicles as mediators of intercellular communication in cancer - the emerging science of cellular 'debris' Semin Immunopathol 33 2011 455 467
19. M.A. Antonyak, B. Li, L.K. Boroughs, J.L. Johnson, J.E. Druso, and K.L. Bryant Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells Proc Natl Acad Sci U S A 108 2011 4852 4857
20. L.G. Lima, R. Chammas, R.Q. Monteiro, M.E. Moreira, and M.A. Barcinski Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner Cancer Lett 283 2009 168 175
21. L.N. Medeiros, R. Angeli, C.G. Sarzedas, E. Barreto-Bergter, A.P. Valente, and E. Kurtenbach Backbone dynamics of the antifungal Psd1 pea defensin and its correlation with membrane interaction by NMR spectroscopy Biochim Biophys Acta 1798 2010 105 113
22. V.S. De Paula, G. Razzera, E. Barreto-Bergter, F.C. Almeida, and A.P. Valente Portrayal of complex dynamic properties of sugarcane defensin 5 by NMR: multiple motions associated with membrane interaction Structure 19 2011 26 36
23. G. Gao, J.G. Williams, and S.L. Campbell Protein-protein interaction analysis by nuclear magnetic resonance spectroscopy Methods Mol Biol 261 2004 79 92
24. A.G. Palmer NMR characterization of the dynamics of biomacromolecules Chem Rev 104 2004 3623 3640
25. M. Pazgier, D.M. Hoover, D. Yang, W. Lu, and J. Lubkowski Human β-defensins Cell Mol Life Sci 63 2006 1294 1313
26. D.M. Hoover, O. Chertov, and J. Lubkowski The structure of human beta-defensin-1: new insights into structural properties of beta-defensins J Biol Chem 276 2001 39021 39026
27. D.M. Hoover, K.R. Rajashankar, R. Blumenthal, A. Puri, J.J. Oppenheim, and O. Chertov The structure of human beta-defensin-2 shows evidence of higher order oligomerization J Biol Chem 275 2000 32911 32918
28. D.J. Schibli, H.N. Hunter, V. Aseyev, T.D. Starner, J.M. Wiencek, and P.B. McCray The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus J Biol Chem 277 2002 8279 8289
29. P. Dosset, J.C. Hus, M. Blackledge, and D. Marion Efficient analysis of macromolecular rotational diffusion from heteronuclear relaxation data J Biomol NMR 16 2000 23 28
30. J. Garcia de la Torre, M.L. Huertas, and B. Carrasco HYDRONMR: prediction of NMR relaxation of globular proteins from atomic-level structures and hydrodynamic calculations J Magn Reson 147 2000 138 146
31. D.S. Wishart Interpreting protein chemical shift data Prog Nucl Magn Reson Spectrosc 58 2011 62 87
32. B. Frey, and U.S. Gaipl The immune functions of phosphatidylserine in membranes of dying cells and microvesicles Semin Immunopathol 33 2011 497 516
33. Y. Lu, Z. Cai, G. Xiao, Y. Liu, E.T. Keller, and Z. Yao CCR2 expression correlates with prostate cancer progression J Cell Biochem 101 2007 676 685
34. C.T. Veldkamp, C. Seibert, F.C. Peterson, T.P. Sakmar, and B.F. Volkman Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1α (SDF-1α/CXCL12) Mol Biol 359 2006 1400 1409
35. L. Duma, D. Häussinger, M. Rogowski, P. Lusso, and S. Grzesiek Recognition of RANTES by extracellular parts of the CCR5 receptor J Mol Biol 365 2007 1063 1075
36. J.Z. Zhu, C.J. Millard, J.P. Ludeman, L.S. Simpson, D.J. Clayton, and R.J. Payne Tyrosine sulfation influences the chemokine binding selectivity of peptides derived from chemokine receptor CCR3 Biochemistry 50 2011 1524 1534
37. L.J. Drury, J.J. Ziarek, S. Gravel, C.T. Veldkamp, T. Takekoshi, and S.T. Hwang Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways Proc Natl Acad Sci U S A 108 2011 17655 17660
38. K. Henzler-Wildman, and D. Kern Dynamic personalities of proteins Nature 450 2007 964 972
39. M. Pazgier, A. Prahl, D.M. Hoover, and J. Lubkowski Studies of the biological properties of human beta-defensin 1 J Biol Chem 19 2007 1819 1829
40. Y. Shen, F. Delaglio, G. Cornilescu, and A. Bax TALOS +: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts J Biomol NMR 44 2009 213 223
41. R. Keller, and K. Wuthrich Computer-aided resonance assignment (CARA) Available at: http://www.nmr.ch 2004
42. F. Delaglio, S. Grzesiek, G.W. Vuister, G. Zhu, J. Pfeifer, and A. Bax NMRPipe: a multidimensional spectral processing system based on UNIX pipes J Biomol NMR 6 1995 277 293
43. G. Lipari, and A. Szabo Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 2. Analysis of experimental results J Am Chem Soc 104 1982 4559 4570
44. H. Schägger, and G. von Jagow Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form Anal Biochem 199 1991 223 231
45. L.G. Lima, A.S. Oliveira, L.C. Campos, M. Bonamino, R. Chammas, and C. Werneck Malignant transformation in melanocytes is associated with increased production of procoagulant microvesicles Thromb Haemost 106 2011 712 723
46. S.J. de Vries, M. van Dijk, and A.M. Bonvin The HADDOCK web server for data-driven biomolecular docking Nat Protoc 5 2010 883 897
47. C. Zwahlen, P. Legault, S.J.F. Vincent, J. Greenblatt, R. Konrat, and L.E. Kay J Am Chem Soc 119 1997 6711 6721
48. W.L. DeLano The PyMOL user's manual 2002 DeLano Scientific Palo Alto, CA
49. M. Krzeminski, K. Loth, R. Boelens, and A.M. Bonvin SAMPLEX: automatic mapping of perturbed and unperturbed regions of proteins and complexes BMC Bioinformatics 11 2010 51 55
50. J.H. Tan, J.P. Ludeman, J. Wedderburn, M. Canals, P. Hall, and S.J. Butler Tyrosine sulfation of chemokine receptor CCR2 enhances interactions with both monomeric and dimeric forms of the chemokine monocyte chemoattractant protein-1 (MCP-1) J Biol Chem 288 2013 10024 10034
51. J.P. Linge, S.I. O'Donnnoghue, and M. Nilges Automated assignment of ambiguous nuclear overhauser effects with ARIA Methods Enzymol 339 2001 71 90
52. A.T. Brunger, P.D. Adams, G.M. Clore, W.L. DeLano, P. Gros, and R.W. Grosse-Kunstleve Crystallography & NMR system: a new software suite for macromecular structure determination Acta Crystallogr 54 1998 905 921
53. R. Koradi, M. Billeter, and K. Wuthrich MOLMOL: a program for display and analysis of macromolecular structure J Mol Graphics 14 1996 51 55
54. R.A. Laskowski, M.W. MacArthur, D.S. Moss, and J.M. Thornton PROCHECK: a program to check the stereochemical quality of protein structures J Appl Crystallogr 26 1993 283 291
55. W.F. Vranken, W. Boucher, T.J. Stevens, R.H. Fogh, A. Pajon, and P. Llinas The CCPN data model for NMR spectroscopy: development of a software pipeline Proteins 59 2005 687 696
56. J.F. Doreleijers, A.W. Sousa da Silva, E. Krieger, S.B. Nabuurs, C.A. Spronk, and T.J. Stevens CING: an integrated residue-based structure validation program suite J Biomol NMR 54 2012 267 283
57. A. Bhattacharya, R. Tejero, and G.T. Montelione Evaluating protein structures determined by structural genomics consortia Proteins 66 2007 778 795
58. J. Liu, S. Louie, W. Hsu, K.M. Yu, H.B. Nicholas Jr., and G.L. Rosenquist Tyrosine sulfation is prevalent in human chemokine receptors important in lung disease Am J Respir Cell Mol Biol 38 2008 738 743
59. M. Farzan, T. Mirzabekov, P. Kolchinsky, R. Wyatt, M. Cayabyab, and N.P. Gerard Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry Cell 96 1999 667 676
60. E. Schnur, E. Noah, I. Ayzenshtat, H. Sargsyan, T. Inui, and F.X. Ding The conformation and orientation of a 27-residue CCR5 peptide in a ternary complex with HIV-1 gp120 and a CD4-mimic peptide J Mol Biol 410 2011 778 797